To date, mutations in at least 15 genes, including FKTN, encoding fukutin, have been identified as causative for secondary dystroglycanopathies [10–13]. This evidence concerns the gene FKTN and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.